Definium Therapeutics (DFTX) Goodwill (2021 - 2026)

Definium Therapeutics (DFTX) has reported Goodwill for 5 consecutive years, with $19.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Goodwill changed 0.0% year-over-year to $19.9 million; the TTM figure through Dec 2025 stood at $19.9 million (changed 0.0% YoY), while the FY2025 annual figure was $19.9 million, changed 0.0% from the prior year.
• Goodwill steadied at $19.9 million in Q4 2025 per DFTX's latest filing, from $19.9 million in the prior quarter.
• Across five years, Goodwill topped out at $19.9 million in Q4 2021 and bottomed at $19.9 million in Q4 2021.
• Historically, Goodwill has averaged $19.9 million across 5 years, with a median of $19.9 million in 2021.
• On a YoY basis, Goodwill climbed as much as 0.0% in 2022 and fell as far as 0.0% in 2022.
• Definium Therapeutics' Goodwill stood at $19.9 million in 2021, then changed by 0.0% to $19.9 million in 2022, then changed by 0.0% to $19.9 million in 2023, then changed by 0.0% to $19.9 million in 2024, then changed by 0.0% to $19.9 million in 2025.
• Business Quant data shows DFTX's Goodwill at $19.9 million in Q4 2025, $19.9 million in Q2 2025, and $19.9 million in Q1 2025.